Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report

被引:3
|
作者
Jung, B. -H. [1 ]
Park, J. -I. [1 ]
Lee, S. -G. [2 ]
机构
[1] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Surg, 875 Haeundae Ro, Busan 48108, South Korea
[2] Univ Ulsan, Asan Med Ctr, Div Hepatobiliary Surg & Liver Transplantat, Dept Surg,Coll Med, Seoul, South Korea
关键词
DRUG-INDUCED HEPATOTOXICITY; RISK-FACTORS; INFECTION; RECIPIENTS; POLYMORPHISMS; MANAGEMENT; HEPATITIS; DIAGNOSIS; THERAPY; FAILURE;
D O I
10.1016/j.transproceed.2018.02.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although active tuberculosis (TB) is considered a contraindication for liver transplantation (LT), this is the only treatment in patients with liver failure and concurrent active TB. We report a case with successful urgent living-donor LT for irreversible liver failure in the presence of active TB. Case Presentation. A 48-year-old man, with a history of decompensated alcoholic liver cirrhosis, was presented with stupor. At admission, his consciousness had deteriorated to semi-coma, and his renal function also rapidly deteriorated to hepatorenal syndrome. A preoperative computed tomography scan of the chest revealed several small cavitary lesions in both upper lobes, and acid-fast bacillus stain from his sputum was graded 2+. Adenosine deaminase levels from ascites were elevated, suggesting TB peritonitis. A first-line anti-TB drug regimen was started immediately (rifampin, isoniazid, levofloxacin, and amikacin). An urgent living-donor LT was performed 2 days later. After LT, the regimen was changed to second-line anti-TB drugs (amikacin, levofloxacin, cycloserine, and pyridoxine). The sputum acid fast bacillus stain tested negative on postoperative day 10. His liver function remained well preserved, even after the reversion to first-line anti-TB treatment. The patient recovered without any anti-TB medication-related complications and was discharged. Conclusions. LT can be prudently performed as a life-saving option, particularly for patients with liver failure and concurrent active TB.
引用
收藏
页码:910 / 914
页数:5
相关论文
共 50 条
  • [41] Repeated dexmedetomidine infusions, a postoperative living-donor liver transplantation patient
    Terajima K.
    Takeda S.
    Taniai N.
    Tanaka K.
    Oda Y.
    Asada A.
    Sakamoto A.
    Journal of Anesthesia, 2006, 20 (3) : 234 - 236
  • [42] "No go" donor hepatectomy in living-donor liver transplantation
    Pamecha, Viniyendra
    Bharathy, Kishore G. S.
    Mahansaria, Shyam S.
    Sinha, Piyush K.
    Rastogi, Archana
    Sasturkar, Shridhar V.
    HEPATOLOGY INTERNATIONAL, 2018, 12 (01) : 67 - 74
  • [43] Living-donor liver transplantation in an HIV-positive patient with hemophilia
    Sugawara, Y
    Ohkubo, T
    Makuuchi, M
    Kimura, S
    Tachikawa, N
    Oka, S
    TRANSPLANTATION, 2002, 74 (11) : 1655 - 1656
  • [44] Apheresis therapy for living-donor liver transplantation - Experience of apheresis use for living-donor liver transplantation at Kyoto university
    Kozaki, K
    Kasahara, M
    Oike, F
    Ogawa, K
    Fujimoto, Y
    Ogura, Y
    Ueda, M
    Kaihara, S
    Fukatsu, A
    Tanaka, K
    THERAPEUTIC APHERESIS, 2002, 6 (06): : 478 - 483
  • [45] Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation A case report
    Lee, Tae Beom
    Yang, Kwangho
    Ko, Hyo Jung
    Shim, Jae Ryong
    Choi, Byung Hyun
    Lee, Jung Hee
    Ryu, Je Ho
    MEDICINE, 2021, 100 (25) : E26463
  • [46] Living-donor liver transplantation for acute liver failure
    Moray, G.
    Sevmis, S.
    Torgay, A.
    Ozcay, F.
    Yilmaz, U.
    Haberal, M.
    LIVER INTERNATIONAL, 2006, 26 : 21 - 21
  • [47] Living-donor liver transplantation for polycystic liver disease
    Ueda, M
    Egawa, H
    Oike, F
    Taira, K
    Uryuhara, K
    Fujimoto, Y
    Kozaki, K
    Tanaka, K
    TRANSPLANTATION, 2004, 77 (03) : 480 - 481
  • [48] Use of discarded liver in living-donor liver transplantation
    Wang, Xingru
    Li, Jianwei
    Zheng, Shuguo
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (04) : 749 - 751
  • [49] The optimal timing of living-donor liver transplantation
    Alagoz, O
    Maillart, LM
    Schaefer, AJ
    Roberts, MS
    MANAGEMENT SCIENCE, 2004, 50 (10) : 1420 - 1430
  • [50] Living-donor liver transplantation for hepatocellular carcinoma
    Kaihara, S
    Kiuchi, T
    Ueda, M
    Oike, F
    Fujimoto, Y
    Ogawa, K
    Kozaki, K
    Tanaka, K
    TRANSPLANTATION, 2003, 75 (03) : S37 - S40